Suchergebnisse - "Kabamba-Mukadi, Benoît"

PubPharm (45)

11

Large-scale, molecular and serological SARS-CoV-2 screening of healthcare workers in a 4-site public hospital in Belgium after COVID-19 outbreak

enthalten in: The Journal of infection | 2021

von Blairon, L. | Mokrane, S. | Wilmet, A. | +4

CommentOn: J Infect. 2020 Sep;81(3):420-426. - PMID 32504745

12

Clinical usefulness of fully automated chemiluminescent immunoassay for quantitative antibody measurements in COVID‐19 patients

enthalten in: Journal of Medical Virology | 2021

von Soleimani, R. | Khourssaji, M. | Gruson, D. | +5

13

Analytical and clinical evaluation of new automated chemiluminescent immunoassays for the detection of IgG and IgM anti-Bartonella henselae antibodies

enthalten in: Diagnostic microbiology and infectious disease | 2020

von Bayart, J. | Gusbin, C. | Lardinois, B. | +2

14

Low performance of rapid antigen detection test as frontline testing for COVID-19 diagnosis

enthalten in: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology | 2020

von Scohy, A. | Anantharajah, A. | Bodéus, M. | +3

CommentIn: J Clin Virol. 2020 Oct;131:104612. - PMID 32871543

15

How to choose the right real-time RT-PCR primer sets for the SARS-CoV-2 genome detection?

enthalten in: ResearchSquare.com | 2020

von Anantharajah, A. | Helaers, R. | Defour, J. | +11

16

HIV-1 and HIV-2 differentially regulate NF-κB activity during the late stages of the replication cycle through BST-2/tetherin antagonism

enthalten in: bioRxiv.org | 2020

von Dufrasne, F. | Dessilly, G. | Lucchetti, M. | +6

17

Biotin interferences : Have we neglected the impact on serological markers?

enthalten in: Clinica chimica acta; international journal of clinical chemistry | 2020

von Bayart, J. | Favresse, J. | Stoefs, A. | +6

18

Comparison of Sanger sequencing for hepatitis C virus genotyping with a commercial line probe assay in a tertiary hospital

enthalten in: BMC infectious diseases | 2019

von Goletti, S. | Zuyten, S. | Goeminne, L. | +6

19

Comparison of Sanger sequencing for hepatitis C virus genotyping with a commercial line probe assay in a tertiary hospital

enthalten in: BMC infectious diseases | 2019

von Goletti, S. | Zuyten, S. | Goeminne, L. | +6

20

Comparison of Sanger sequencing for hepatitis C virus genotyping with a commercial line probe assay in a tertiary hospital

enthalten in: BMC infectious diseases | 2019

von Goletti, S. | Zuyten, S. | Goeminne, L. | +6